News & AnalysisGyroscope Therapeutics lands $148m Series CGyroscope Therapeutics, a gene therapy company, has raised $148 million in Series C financing.ByIris Dorbian26 March 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs